Using PDE 3/4 Inhibitors to Treat COPD Live Broadcast
Original price was: $10.00.$5.00Current price is: $5.00.
If you purchased the course or have an Annual CEU Subscription, join the Zoom class by clicking here.
This broadcast is sponsored by Verona Pharma. Verona Pharma develops novel treatments to enhance the lives of those affected by chronic lung conditions. Their drug Ohtuvayre was FDA approved in 2024 and is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. Their sponsorship is allowing you to take this course for only $5.
Purchasing this course allows you to participate in the live broadcast airing on Monday, January 20, 2025. Course times this day are:
| 9:00 AM | Eastern |
| 8:00 AM | Central |
| 7:00 AM | Mountain |
| 6:00 AM | Pacific |
Please note this is not a course that may be taken at any time.
If you miss a Real-Time Live Broadcast you paid to attend, we can move you to another broadcast, enroll you in either a Recorded Live Credit or Self-Directed course, all of the same value, or refund your purchase. Just let us know your choice and we’ll make it happen.
Sale!
